Incyte paid its 7 named executives $70.1M in total in FY2025 (Dec). CEO Hervé Hoppenot was paid $6.4M of that.
Pay$100 in the stock at the end of FY20 → $162
Pay of each named executive
William J. MeuryChief Executive Officer
| FY2025 (Dec) |
1 year
Mohamed IssaExecutive Vice President and Head of U.S. Commercial
| FY2025 (Dec) |
1 year
Pablo J. CagnoniPresident, Research and Development
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Hervé HoppenotPresident and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Steven H. SteinExecutive Vice President and Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Christiana StamoulisExecutive Vice President and Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Thomas TrayVice President, Chief Accounting Officer and Principal Financial Officer
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.